Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel
May the force be with you: the power of next-generation sequencing
Novel methods to assess the effectiveness of chemotherapy in AML patients: MRD
How does a patient’s personal situation affect CLL treatment choice?
T-cell lymphoma: autologous or allogeneic transplant?